Pancreatin

Metabolism

OTC

VED

Pancreatin  

Pancreatin

OTC

VED

Active ingredient (INN)
pancreatin
Composition (active ingredients)
pancreatin with minimal enzymatic activity: amylase - 4200 U, lipase - 3500 U, protease - 250 U
Фармакотерапевтическая группа
digestive enzyme
Pharmacotherapeutic group
enteric tablets, film-coated 3500 U
Сonditions of supply
no prescription
Indications

Indications

Taking pancreatin significantly reduces the symptoms of pancreatic enzyme deficiency, including abdominal pain, flatulence, changes in stool frequency and consistency, regardless of the etiology of the disease. The enzymes of the pancreas, which are part of the drug, are released from the tablet in the alkaline medium of the small intestine, as they are protected from the action of gastric juice by the enteric coating. Facilitate the breakdown of proteins, fats and carbohydrates, which leads to their complete absorption in the small intestine.
  • disorders of the enzymatic (exocrine) function of the pancreas in diseases of the gastrointestinal tract, accompanied by indigestion
  • to improve food digestion in patients with normal gastrointestinal tract function with nutritional inaccuracies

Contraindications

There are contraindications, consult with a specialist before use